Clinical Trial Update: Efficacy and Safety of HMAs Combined With Venetoclax Versus HMAs Alone in ND Int-and H-risk MDS or CMML

View source ↗

Summary

This clinical trial update covers the efficacy and safety of combining hypomethylating agents with venetoclax versus hypomethylating agents alone in newly diagn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome
• Myelomonocytic Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Decitabine (Decitabine)
• Venetoclax (venetoclax)

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: MDS, CMML | Status: ACTIVE_NOT_RECRUITING